Allelica offers state-of-the-art tools designed to integrate genetics into clinical practice to reduce the burden of common disease. We enable physicians to provide cutting-edge personalized risk assessments across a range of conditions. The Allelica platform enhances traditional care with comprehensive genetic insights, allowing for more precise, evidence-based interventions.
Allelica’s Polygenic Risk Scores (PRS) identify patients at increased genetic risk for various diseases, even when traditional risk factors are absent. This empowers physicians to implement targeted preventive measures early on avoiding unnecessary suffering
Seamlessly integrate genetic risk data into your workflow. Allelica provides actionable insights that support clinical decision-making, from pharmacologic treatments to personalized care strategies.
Leveraging large-scale prospective data, Allelica’s PRSs offer a reliable tool to complement your existing clinical assessments and enhance patient care across diverse populations
Select patients who may benefit from a comprehensive genetic risk assessment for various conditions, including cardiovascular, metabolic, oncological, and more.
Patients provide a buccal sample, which is processed in one of Allelica’s CLIA-certified and CAP-accredited laboratory partners to ensure high-quality and accurate results.
Receive personalized PRS reports that quantify genetic risk relative to a reference population, providing insights that can guide clinical decision-making and patient management.
Allelica’s platform supports proactive management of a wide spectrum of health conditions, offering genetic insights that inform treatment decisions, optimize therapeutic approaches, and enhance overall patient outcomes. Whether assessing risk in young adults or refining risk in patients with unclear clinical profiles, PRS adds a predictive dimension to traditional risk models.
Allelica’s agile quality management system (QMS) is tailored for clinical genetic test development, providing biotech and pharmaceutical companies with the expertise and advanced software needed to bring new assays from concept to market. Our comprehensive platform supports every stage of the process, from design and validation to regulatory compliance and commercialization, ensuring that your genetic tests meet rigorous clinical and industry standards. Partner with Allelica to accelerate your pipeline and deliver innovative genetic solutions with confidence.
Allelica’s advanced PRS technology equips physicians with the tools needed to advance precision medicine. By incorporating genetic risk scores into routine practice, you can identify high-risk patients across multiple disease categories, tailor interventions more effectively, and lead the way in personalized healthcare.
Allelica’s bioinformatics platform empowers laboratories to bring clinical PRS, pharmacogenetics, and carrier screening analyses in-house with confidence. Available as both cloud-based and on-premise solutions when data cannot leave the building. Allelica software is designed for seamless integration into your existing workflows. With customizable panels and multilingual, white-label reporting, Allelica provides the flexibility and scalability needed to meet your lab’s specific needs while maintaining the highest standards of security and performance. Elevate your lab's capabilities with Allelica’s advanced, adaptable tools.
"With this agreement, Merck confirms its strong commitment to advancing science and technology in the area of cardiovascular disease"
Our products are developed and validated using world class datasets and state-of-the-art technology to ensure the highest level of quality.
We are a group of international scientists and researchers committed to maintaining standards of academic excellence every step of the way.
Everything we do works towards our common goal of providing tangible improvement in preventive healthcare to help humans live a longer, healthier life.